Filing Details
- Accession Number:
- 0001209191-13-021463
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-16 14:49:25
- Reporting Period:
- 2013-04-12
- Filing Date:
- 2013-04-16
- Accepted Time:
- 2013-04-16 14:49:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1396814 | Pacira Pharmaceuticals Inc. | PCRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1283535 | Gary Patou | C/O Mpm Asset Management 601 Gateway Blvd., Suite 350 South San Francisco CA 94080 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-04-12 | 10,000 | $1.61 | 10,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-04-12 | 10,000 | $30.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2013-04-12 | 10,000 | $0.00 | 10,000 | $1.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
19,042 | 2020-09-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 115 | Indirect | See Footnote |
Footnotes
- This transaction was pursuant to a 10b5-1 Plan.
- Shares held by Patou Family Trust, of which the reporting person is trustee.
- The option vests as to 50% of the option shares on September 2, 2010 and the remaining 50% of the option shares vests equally monthly over the next 24 months.